"
Degital Therapeutics Market to be worth $ 42.98  Billion By 2030”


 

 

 

Meticulous Research®—a leading global market research company, published a research report titled Digital Therapeutics Market by Application (Mental Health, Diabetes, Respiratory, Neurology, Gastrointestinal, Cardiovascular, Addiction, Rehabilitation, Oncology, Sleep Disorder), Type (Disease Prevention, Management), End User - Global Forecast to 2030.’

 Download Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5427

According to this latest publication from Meticulous Research®, the global digital therapeutics market is projected to reach $42.98 billion by 2030 at a CAGR of 31.1%. The growth of this market is mainly attributed to the increasing need to reduce healthcare costs, the rising prevalence of chronic diseases, the high adoption of digital healthcare, and the increasing focus on preventive healthcare. Moreover, emerging economies and expanding pipelines for digital therapeutic solutions for various therapy areas offer significant opportunities for the growth of this market.

Key Players

The key players operating in the global digital therapeutics market are Noom, Inc. (U.S.), 2Morrow Inc. (U.S.), GAIA AG (Germany), ResMed Inc. (U.S.), Canary Health (U.S.), Welldoc, Inc. (U.S.), DarioHealth Corp. (U.S.), Akili, Inc. (U.S.), Biofourmis Inc. (U.S.), BigHealth (U.S.), Teladoc Health, Inc. (U.S.), Limbix Health, Inc. (U.S.), Kaia Health Software Inc. (Germany), Glooko, Inc. (U.S.), and Virta Health Corp. (U.S.).

Digital Therapeutics Market: Future Outlook

The global digital therapeutics market is segmented by Type (Disease Management and Treatment DTx and Disease Prevention DTx), Applications (Mental Health, Diabetes, Cardiovascular Diseases, Gastrointestinal Disorders, Neurology, Rehabilitation & patient care, Respiratory Disorders, Oncology, Addiction Management, Sleep Disorders, Smoking Cessation, and Other Applications), End User (Providers, Individual Consumers, Employers, Payers, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Based on type, in 2023, the disease management and treatment DTx segment is expected to account for the largest share of the digital therapeutics market. The large market share of this segment is attributed to the availability of cost-effective mHealth platforms, the increasing need to control healthcare costs, high investments in digital health, and strategic collaborations among stakeholders to launch disease treatment and management of digital therapeutic platforms.

Based on application, the digital therapeutics market is segmented into mental health, diabetes, cardiovascular diseases, gastrointestinal disorders, neurology, rehabilitation and patient care, oncology, respiratory disorders, addiction management, sleep disorders, smoking cessation, and other applications. In 2023, the mental health segment is expected to account for the largest share of the digital therapeutics market due to the increasing prevalence of mental issues, such as stress, anxiety, and depression. Additionally, loss in productivity by mental health issues and the need for cost-effective solutions for stress and depression management are contributing to the large market share of this segment.

speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5427

Based on end user, the individual consumers segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to the increasing awareness and approvals of digital therapeutic solutions, the high adoption of mHealth platforms, and the trend of preventive healthcare among patients.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the digital therapeutics market. The large share of this market is attributed to the increased usage of digital health products, the increasing incidence of chronic diseases, and government initiatives to support digital healthcare.

Quick buy: https://www.meticulousresearch.com/Checkout/41755794

Key questions answered in the report-

·  Which are the high-growth market segments in terms of type, application, end user, and regions/countries?

·  What was the historical market for digital therapeutics across the globe?

·  What are the market forecasts and estimates for the period 2023–2030?

·  What are the major drivers, restraints, challenges, opportunities, and trends in the global digital therapeutics market?

·  Who are the major players in the global digital therapeutics market?

·  How is the competitive landscape, and who are the market leaders in the global digital therapeutics market?

·  What are the recent developments in the digital therapeutics market?

·  What are the different strategies adopted by the major players in the digital therapeutics market?

·  What are the geographical trends and high-growth regions/countries? 

 

Contact Us:
Meticulous Research®
Email- 
sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- 
https://www.linkedin.com/company/meticulous-research